Factors associated with mortality in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis
Open Access
- 11 October 2021
- journal article
- review article
- Published by Springer Nature in Respiratory Research
- Vol. 22 (1) , 1-13
Abstract
Background: Interstitial lung disease (ILD) is a common and potentially life-threatening complication for rheumatoid arthritis (RA) patients. However, there is a lack of clear prognostic factors in rheumatoid arthritis-associated interstitial lung disease (RA-ILD) patients. The purpose of this study was to complete a systematic review and meta-analysis of the factors associated with mortality in RA-ILD patients. Methods: Medline, EMBASE and the Cochrane Library were searched up to September 1, 2020. The Newcastle–Ottawa Scale (NOS) was applied to assess the methodological quality of the eligible studies. Study characteristics and magnitude of effect sizes were extracted. Then, pooled hazard ratios (HRs) with the corresponding 95% confidence intervals (CIs) and pooled risk ratios (RRs) with 95% CIs were calculated to assess the factors associated with mortality in RA-ILD. Results: Twenty-three of 3463 articles were eligible, and ten factors associated with mortality for RA-ILD were evaluated in the meta-analysis. Older age (HRs = 1.04, 95% CI 1.03–1.05), male sex (HRs = 1.44, 95% CI 1.21–1.73), having a smoking history (HRs = 1.42, 95% CI 1.03–1.96), lower diffusing capacity of the lung for carbon monoxide (DLCO)% predicted (HRs = 0.98, 95% CI 0.97–1.00), forced vital capacity (FVC)% predicted (HRs = 0.99, 95% CI 0.98–1.00), composite physiological index (CPI) (HRs = 1.04, 95% CI 1.02–1.06), usual interstitial pneumonia (UIP) pattern on HRCT (HRs = 1.88, 95% CI 1.14–3.10 and RRs = 1.90, 95% CI 1.50–2.39), emphysema presence (HRs = 2.31, 95% CI 1.58–3.39), and acute exacerbation of ILD (HRs = 2.70, 95% CI 1.67–4.36) were associated with increased mortality in RA-ILD, whereas rheumatoid factor (RF) positive status was not associated. Conclusions: Through this systematic review and meta-analysis, we found that older age, male sex, smoking history, higher CPI, lower DLCO% predicted, lower FVC% predicted, UIP pattern on HRCT, emphysema presence and acute exacerbation of ILD were associated with an increased risk of mortality in RA-ILD.Keywords
Funding Information
- Yantai Science and Technology Bureau (No. 2020YD024)
This publication has 56 references indexed in Scilit:
- Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: a retrospective case control studyBMJ Open, 2013
- Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD)Respiratory Medicine, 2013
- Lung diseases directly associated with rheumatoid arthritis and their relationship to outcomeEuropean Respiratory Journal, 2010
- Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics RegisterAnnals of the Rheumatic Diseases, 2010
- Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohortRheumatology, 2010
- Incidence and mortality of interstitial lung disease in rheumatoid arthritis: A population‐based studyArthritis & Rheumatism, 2010
- Rheumatoid arthritis treatment and the risk of severe interstitial lung diseaseScandinavian Journal of Rheumatology, 2007
- Histopathologic Pattern and Clinical Features of Rheumatoid Arthritis-Associated Interstitial Lung DiseaseChest, 2005
- Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 yearsAnnals of the Rheumatic Diseases, 2003
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988